Search research articles
Contact Us
Filters
Showing results (31-40 of 136) with videos related to
Page
of 14
Sort By:
Cancer
|
August 9, 2011
Validation of the Royal Marsden Hospital prognostic score in patients treated in the Phase I Clinical Trials Program at the MD Anderson Cancer Center
Ignacio Garrido-Laguna, Filip Janku, Christos Vaklavas, et al.
Investigational New Drugs
|
May 12, 2023
A phase Ib study of adavosertib, a selective Wee1 inhibitor, in patients with locally advanced or metastatic solid tumors
Gerald S Falchook, Jasgit Sachdev, Esteban Rodrigo Imedio, et al.
Journal of Oncology Practice
|
June 23, 2016
Innovative Strategies for Decreasing Blood Collection Wait Times for Patients in Early-Phase Cancer Clinical Trials
Bayabel Mengistu, Dina Ray, Passion Lockett, et al.
Plos One
|
August 11, 2011
PIK3CA mutations frequently coexist with RAS and BRAF mutations in patients with advanced cancers
Filip Janku, J Jack Lee, Apostolia M Tsimberidou, et al.
Drugs in R&D
|
December 23, 2015
Effect of Food on the Pharmacokinetics of the Investigational Aurora A Kinase Inhibitor Alisertib (MLN8237) in Patients with Advanced Solid Tumors
Gerald S Falchook, Xiaofei Zhou, Karthik Venkatakrishnan, et al.
Cancer Chemotherapy and Pharmacology
|
March 21, 2016
Erratum to: Pharmacokinetic evaluation of nanoparticle albumin-bound paclitaxel delivered via hepatic arterial infusion in patients with predominantly hepatic metastases
Siqing Fu, Kirk S Culotta, Gerald S Falchook, et al.
Cancer Chemotherapy and Pharmacology
|
December 25, 2015
Pharmacokinetic evaluation of nanoparticle albumin-bound paclitaxel delivered via hepatic arterial infusion in patients with predominantly hepatic metastases
Fu Siqing, Kirk S Culotta, Gerald S Falchook, et al.
Oncotarget
|
April 19, 2014
Advanced gynecologic malignancies treated with a combination of the VEGF inhibitor bevacizumab and the mTOR inhibitor temsirolimus
Sarina A Piha-Paul, Jennifer J Wheler, Siqing Fu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
February 15, 2015
Olanzapine for cachexia in patients with advanced cancer: an exploratory study of effects on weight and metabolic cytokines
Aung Naing, Shalini Dalal, Maen Abdelrahim, et al.
Plos One
|
June 8, 2012
KRASness and PIK3CAness in patients with advanced colorectal cancer: outcome after treatment with early-phase trials with targeted pathway inhibitors
Ignacio Garrido-Laguna, David S Hong, Filip Janku, et al.
Page
of 14
Search research articles
Search
Showing results (31-40 of 136) with videos related to
Sort By:
Page
of 14
Cancer
|
August 9, 2011
Validation of the Royal Marsden Hospital prognostic score in patients treated in the Phase I Clinical Trials Program at the MD Anderson Cancer Center
Ignacio Garrido-Laguna, Filip Janku, Christos Vaklavas, et al.
Investigational New Drugs
|
May 12, 2023
A phase Ib study of adavosertib, a selective Wee1 inhibitor, in patients with locally advanced or metastatic solid tumors
Gerald S Falchook, Jasgit Sachdev, Esteban Rodrigo Imedio, et al.
Journal of Oncology Practice
|
June 23, 2016
Innovative Strategies for Decreasing Blood Collection Wait Times for Patients in Early-Phase Cancer Clinical Trials
Bayabel Mengistu, Dina Ray, Passion Lockett, et al.
Plos One
|
August 11, 2011
PIK3CA mutations frequently coexist with RAS and BRAF mutations in patients with advanced cancers
Filip Janku, J Jack Lee, Apostolia M Tsimberidou, et al.
Drugs in R&D
|
December 23, 2015
Effect of Food on the Pharmacokinetics of the Investigational Aurora A Kinase Inhibitor Alisertib (MLN8237) in Patients with Advanced Solid Tumors
Gerald S Falchook, Xiaofei Zhou, Karthik Venkatakrishnan, et al.
Cancer Chemotherapy and Pharmacology
|
March 21, 2016
Erratum to: Pharmacokinetic evaluation of nanoparticle albumin-bound paclitaxel delivered via hepatic arterial infusion in patients with predominantly hepatic metastases
Siqing Fu, Kirk S Culotta, Gerald S Falchook, et al.
Cancer Chemotherapy and Pharmacology
|
December 25, 2015
Pharmacokinetic evaluation of nanoparticle albumin-bound paclitaxel delivered via hepatic arterial infusion in patients with predominantly hepatic metastases
Fu Siqing, Kirk S Culotta, Gerald S Falchook, et al.
Oncotarget
|
April 19, 2014
Advanced gynecologic malignancies treated with a combination of the VEGF inhibitor bevacizumab and the mTOR inhibitor temsirolimus
Sarina A Piha-Paul, Jennifer J Wheler, Siqing Fu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
February 15, 2015
Olanzapine for cachexia in patients with advanced cancer: an exploratory study of effects on weight and metabolic cytokines
Aung Naing, Shalini Dalal, Maen Abdelrahim, et al.
Plos One
|
June 8, 2012
KRASness and PIK3CAness in patients with advanced colorectal cancer: outcome after treatment with early-phase trials with targeted pathway inhibitors
Ignacio Garrido-Laguna, David S Hong, Filip Janku, et al.
Page
of 14